Nanoparticle biointerfacing by platelet membrane cloaking

Nature

Volumn 526, Issue 7571, 2015, Pages 118-121

  Hu, Che Ming J ^a,b   Fang, Ronnie H ^a,b   Wang, Kuei Chun ^c,d   Luk, Brian T ^b,c   Thamphiwatana, Soracha ^a,b   Dehaini, Diana ^a,b   Nguyen, Phu ^c,d   Angsantikul, Pavimol ^a,b   Wen, Cindy H ^e   Kroll, Ashley V ^a,b   Carpenter, Cody ^a   Ramesh, Manikantan ^a   Qu, Vivian ^a   Patel, Sherrina H ^e   Zhu, Jie ^e   Shi, William ^e   Hofman, Florence M ^f   Chen, Thomas C ^f   Gao, Weiwei ^a,b   Zhang, Kang ^a,d,e,g   Chien, Shu ^c,d   Zhang, Liangfang ^a,b,d   more..

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; MEMBRANE ANTIGEN; NANOPARTICLE; VANCOMYCIN; ANTIINFECTIVE AGENT; COLLAGEN; LIPOSOME; POLYMER; TAXOID;

ADHESION; ANTIGEN; BACTERIAL DISEASE; IMMUNOASSAY; MEMBRANE; NANOPARTICLE; PLASMA; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BLOOD VESSEL; CELL ADHESION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MATERIAL COATING; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; RAT MODEL; RESTENOSIS; THROMBOCYTE MEMBRANE; UPTAKE ASSAY; ANIMAL; BLOOD; CELL MEMBRANE; CHEMISTRY; CORONARY RESTENOSIS; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; THROMBOCYTE; THROMBOCYTE ADHESION;

BACTERIA (MICROORGANISMS); RATTUS; RODENTIA;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD PLATELETS; BLOOD VESSELS; CELL MEMBRANE; COLLAGEN; COMPLEMENT ACTIVATION; CORONARY RESTENOSIS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; HUMANS; MACROPHAGES; MALE; MICE; NANOPARTICLES; PLATELET ADHESIVENESS; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TAXOIDS; UNILAMELLAR LIPOSOMES; VANCOMYCIN;

EID: 84942901402     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature15373     Document Type: Article

References (30)

1. Pelaz, B. et al. Interfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactions. Small 9, 1573-1584 (2013).
2. Salvati, A. et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nature Nanotechnol. 8, 137-143 (2013).
3. Tenzer, S. et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nature Nanotechnol. 8, 772-781 (2013).
4. Born, G. V. & Cross, M. J. The aggregation of blood platelets. J. Physiol. (Lond.) 168, 178-195 (1963).
5. Kieffer, N. & Phillips, D. R. Platelet membrane glycoproteins: functions in cellular interactions. Annu. Rev. Cell Biol. 6, 329-357 (1990).
6. Fitzgerald, J. R., Foster, T. J. & Cox, D. The interaction of bacterial pathogens with platelets. Nature Rev. Microbiol. 4, 445-457 (2006).
7. Yeaman, M. R. Platelets in defense against bacterial pathogens. Cell. Mol. Life Sci. 67, 525-544 (2010).
8. Peters, D. et al. Targeting atherosclerosis by using modular, multifunctional micelles. Proc. Natl Acad. Sci. USA 106, 9815-9819 (2009).
9. Chan, J. M. et al. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc. Natl Acad. Sci. USA 107, 2213-2218 (2010).
10. Bertram, J. P. et al. Intravenous hemostat: nanotechnology to halt bleeding. Sci. Transl. Med. 1, 11ra22 (2009).
11. Modery-Pawlowski, C. L. et al. Approaches to synthetic platelet analogs. Biomaterials 34, 526-541 (2013).
12. Simberg, D. et al. Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl Acad. Sci. USA 104, 932-936 (2007).
13. Anselmo, A. C. et al. Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano 8, 11243-11253 (2014).
14. Olsson, M., Bruhns, P., Frazier, W. A., Ravetch, J. V. & Oldenborg, P. A. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood 105, 3577-3582 (2005).
15. Sims, P. J., Rollins, S. A. & Wiedmer, T. Regulatory control of complement on blood platelets.Modulation of platelet procoagulant responses by amembrane inhibitor of the C5b-9 complex. J. Biol. Chem. 264, 19228-19235 (1989).
16. Nieswandt, B. & Watson, S. P. Platelet-collagen interaction: is GPVI the central receptor? Blood 102, 449-461 (2003).
17. Hu, C. M. et al. Erythrocytemembrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108, 10980-10985 (2011).
18. Hu, C. M., Fang, R.H., Copp, J., Luk, B. T.& Zhang, L. A biomimetic nanosponge that absorbs pore-forming toxins. Nature Nanotechnol. 8, 336-340 (2013).
19. Hu, C. M., Fang, R. H., Luk, B. T. & Zhang, L. Nanoparticle-detained toxins for safe and effective vaccination. Nature Nanotechnol. 8, 933-938 (2013).
20. Gachet, C. et al. Alpha IIb beta 3 integrin dissociation induced by EDTA results in morphological changes of the platelet surface-connected canalicular system with differential location of the two separate subunits. J. Cell Biol. 120, 1021-1030 (1993).
21. Luk, B. T. et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 6, 2730-2737 (2014).
22. Hughes, C. E. et al. CLEC-2 activates Syk through dimerization. Blood 115, 2947-2955 (2010).
23. Kalluri, R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nature Rev. Cancer 3, 422-433 (2003).
24. Rodriguez,P. L. et al. Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339, 971-975 (2013).
25. Law, S. K. A. & Dodds, A. W. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci. 6, 263-274 (1997).
26. Terstappen, L. W. M. M.,Nguyen, M., Lazarus,H.M.& Medof, M. E. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation. J. Leukoc. Biol. 52, 652-660 (1992).
27. Andersen, A. J., Hashemi, S. H., Andresen, T. L., Hunter, A. C. & Moghimi, S. M. Complement: alive and kicking nanomedicines. J. Biomed. Nanotechnol. 5, 364-372 (2009).
28. Siboo, I. R., Chambers, H. F. & Sullam, P. M. Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infect. Immun. 73, 2273-2280 (2005).
29. Kamaly, N. et al. Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles. Proc. Natl Acad. Sci. USA 110, 6506-6511 (2013).
30. Hu, C. M. et al. 'Marker-of-self' functionalization of nanoscale particles through a top-down cellularmembrane coating approach. Nanoscale 5, 2664-2668 (2013).